A clinical trial to investigate the efficacy, safety and tolerability of ML-004 for treatment of the core behavioural symptoms in Autistic people
Autism
The study evaluates the safety, efficacy and tolerability of investigational drug ML-004, compared to placebo, for treatment of the core symptoms in Autistic people. The study will determine whether treatment with ML-004 results in improved social communication, as well as other aspects of autism.